191 related articles for article (PubMed ID: 2434564)
21. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.
Cronstein BN; Kramer SB; Weissmann G; Hirschhorn R
J Exp Med; 1983 Oct; 158(4):1160-77. PubMed ID: 6311934
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor.
Berkow RL; Wang D; Larrick JW; Dodson RW; Howard TH
J Immunol; 1987 Dec; 139(11):3783-91. PubMed ID: 2824615
[TBL] [Abstract][Full Text] [Related]
23. DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats.
Yu HP; Hsieh PW; Chang YJ; Chung PJ; Kuo LM; Hwang TL
Biochem Pharmacol; 2009 Oct; 78(8):983-92. PubMed ID: 19540209
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of neutrophil function in vitro by nimesulide. Preliminary evidence of an adenosine-mediated mechanism.
Capecchi PL; Ceccatelli L; Beermann U; Laghi Pasini F; Di Perri T
Arzneimittelforschung; 1993 Sep; 43(9):992-6. PubMed ID: 8240466
[TBL] [Abstract][Full Text] [Related]
25. Homologous priming in chemotactic peptide-stimulated neutrophils.
Bellavite P; Chirumbolo S; Lippi G; Guzzo P; Santonastaso C
Cell Biochem Funct; 1993 Jun; 11(2):93-100. PubMed ID: 8391938
[TBL] [Abstract][Full Text] [Related]
26. Viscolin, a new chalcone from Viscum coloratum, inhibits human neutrophil superoxide anion and elastase release via a cAMP-dependent pathway.
Hwang TL; Leu YL; Kao SH; Tang MC; Chang HL
Free Radic Biol Med; 2006 Nov; 41(9):1433-41. PubMed ID: 17023270
[TBL] [Abstract][Full Text] [Related]
27. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.
Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE
Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820
[TBL] [Abstract][Full Text] [Related]
28. Substance P activates and modulates neutrophil oxidative metabolism and aggregation.
Hafström I; Gyllenhammar H; Palmblad J; Ringertz B
J Rheumatol; 1989 Aug; 16(8):1033-7. PubMed ID: 2479743
[TBL] [Abstract][Full Text] [Related]
29. The effects of adenosine agonists on human neutrophil function.
Schrier DJ; Imre KM
J Immunol; 1986 Nov; 137(10):3284-9. PubMed ID: 3021850
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil.
Fantone JC; Marasco WA; Elgas LJ; Ward PA
J Immunol; 1983 Apr; 130(4):1495-7. PubMed ID: 6300229
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
[TBL] [Abstract][Full Text] [Related]
32. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.
Azuma Y; Kosaka K; Kashimata M
Eur J Pharmacol; 2007 Jul; 568(1-3):260-8. PubMed ID: 17560994
[TBL] [Abstract][Full Text] [Related]
33. Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids.
Goetzl EJ; Brash AR; Tauber AI; Oates JA; Hubbard WC
Immunology; 1980 Apr; 39(4):491-501. PubMed ID: 6247265
[TBL] [Abstract][Full Text] [Related]
34. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
Eda R; Townley RG; Hopp RJ
Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
[TBL] [Abstract][Full Text] [Related]
35. Dual effects of formylpeptides on the adhesion of endotoxin-primed human neutrophils.
Bellavite P; Chirumbolo S; Lippi G; Andrioli G; Bonazzi L; Ferro I
Cell Biochem Funct; 1993 Dec; 11(4):231-9. PubMed ID: 7903912
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
Perez HD; Elfman F; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
[TBL] [Abstract][Full Text] [Related]
37. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
38. (2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
Huang YJ; Chen IS; Tseng CP; Day YJ; Lin YC; Liao CH
Biochem Pharmacol; 2008 Feb; 75(3):688-97. PubMed ID: 17988652
[TBL] [Abstract][Full Text] [Related]
39. Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils.
Sullivan GW; Lee DD; Ross WG; DiVietro JA; Lappas CM; Lawrence MB; Linden J
J Leukoc Biol; 2004 Jan; 75(1):127-34. PubMed ID: 14525968
[TBL] [Abstract][Full Text] [Related]
40. Staurosporine and its derivatives enhance f-Met-Leu-Phe-induced superoxide production via phospholipase D activation in human polymorphonuclear leukocytes.
Mori T; Ando M; Takagi K
Int J Clin Pharmacol Ther; 1994 Aug; 32(8):422-8. PubMed ID: 7981927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
